Skip to Content

DNA Print Genomics Inc DNAG Stock Quote

| Rating as of

GREY:DNAG

Morningstar‘s Stock Analysis DNAG

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics DNAG

Company Profile DNAG

Business Description

DNA Print Genomics Inc is a pharmaceutical company that focuses on the human genome sciences. Through its subsidiaries, it is into research and development of genomic products and provides scientific services and tests to the genealogy, forensic, pharmaceutical, and genetics markets; and focuses on personalized medicine; and other operations.

Contact
1621 West University Parkway
Sarasota, FL, 34243
T +1 941 366-3400
Industry Biotechnology
Most Recent Earnings Sep 30, 2007
Fiscal Year End Dec 31, 2012
Employees 25